Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
516
2
3
452
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
11.0%
57 terminated/withdrawn out of 516 trials
88.8%
+2.2% vs industry average
43%
223 trials in Phase 3/4
18%
82 of 452 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (516)
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Role: collaborator
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
Role: collaborator
Fibulink Syndesmosis Repair System With Early Full-Weight Bearing
Role: collaborator
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
Role: collaborator
A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants
Role: lead
Reward Emotion Learning and Ketamine Study
Role: collaborator
A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
Role: lead
MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation
Role: collaborator
Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus
Role: collaborator
The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive
Role: collaborator
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
Role: lead
A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis
Role: lead
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
Role: collaborator
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Role: collaborator
A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy
Role: collaborator
A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Role: collaborator
Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)
Role: collaborator
Laparoscopic Approach to Cancer of the Endometrium
Role: collaborator
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
Role: lead
Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Otherwise Healthy Obese Volunteers
Role: lead